| 1419590-17-2

• CAS: 1419590-17-2
• 化学式: C₁₈H₁₅ClN₂Pd
• 分子量: 406.164
• InChiKey: LMEXBJCKCFGZQZ-YPHBCESESA-M

计算性质

• 辛醇/水分配系数(LogP)：
  None
• 重原子数：
  None
• 可旋转键数：
  None
• 环数：
  None
• sp3杂化的碳原子比例：
  None
• 拓扑面积：
  None
• 氢给体数：
  None
• 氢受体数：
  None

反应信息

• 作为产物：
  描述：

  氘代吡啶 、 [Pd{C₆H₄CPh=NH}(μ-Cl)]₂ 以 氘代氯仿 为溶剂， 生成
  参考文献：
  名称：

  Cyclopalladated benzophenone imines: Synthesis, cytotoxicity against human breast adenocarcinoma cell lines and DNA interaction

  摘要：

  Treatment of benzophenone imine with the stoichiometric amount of Pd(OAc)(2) in acetic acid at 60 degrees C produced the corresponding acetato-bridged five-membered ortho-cyclopalladated dimer [Pd{C6H4CPh = NH}(mu-OAc)](2) (1), which was isolated in pure form in a 79% yield. Reaction of 1 with an excess of LiCl in acetone gave rise to the corresponding chlorido-bridged cyclopalladated dimer [Pd{C6H4CPh = NH}(mu-Cl)](2) (2) in a 78% yield. Compounds 1-2 reacted with an excess of py-d(5) or the stoichiometric amount of PPh3 to give the mononuclear compounds trans-N,L-[Pd{C6H4CPh = NH}(X)(L)] [3 (X = OAc, L = py-d(5)); 4 (X = Cl, L = py-d(5)); 5 (X = OAc, L = PPh3) and 6 (X = Cl, L = PPh3)]. Compounds 2-3 were prepared in CDCl3/py-d(5) solution and were studied by H-1 NMR, but were not isolated. In contrast, compounds 5-6 were prepared in acetone and were isolated in pure form in 43 and 79% yields, respectively. Compounds 1, 2, 5 and 6 were characterized by elemental analyses, mass spectrometry, IR, NMR and electronic spectroscopy. Compounds 1, 2, 5 and 6 showed high antiproliferative activity against MDA-MB231 and MCF7 human breast cancer cell lines, especially, compounds 5-6. These two latter compounds presented greater antiproliferative activity than cisplatin and produced IC50 values in the range 1-5 mu M. The interaction of compounds 1, 2, 5 and 6 with DNA was also studied by the DNA electrophoretic migration, DNA-ethidium bromide fluorescence quenching and viscometry techniques. (C) 2012 Elsevier B.V. All rights reserved.

  DOI：

  10.1016/j.jorganchem.2012.11.034